CAFs have been reported to secrete COL1A1 and facilitate the metastasis of ovarian cancer [80], and an oncogenic role of extracellular vesicles-encapsulated leukocyte protease inhibitor secreted by CAFs has been demonstrated in ovarian tumor progression [81]. This evidence concerns the gene COL1A1 and ovarian neoplasm.